Abstract: Water based aerosol coatings which comprise water reducible resin, dimethylether, water and water soluble solvent are described. The improved water reducible aerosol coatings can be cleaned up with water, have high gloss, are non-flammable and contain no aromatic hydrocarbons such as toluene or xylene.
Abstract: Use of ethyl hydroxy ethyl cellulose to aid in dispersion and suspension of pigment and control of application rheology in inorganic zinc-rich primers made with partially hydrolyzed ethyl silicate resins is described.
Abstract: An improved method of preparing hydrolyzed alkyl silicate binders useful in manufacturing protective coatings, i.e., zinc-rich coatings, is described wherein the hydrolysis is catalyzed in the presence of a strong acid form ion exchange resin instead of a conventional acid catalyst.
Abstract: The present invention provides 2-substituted quinuclidines of the formula ##STR1## and the pharmaceutically acceptable acid addition salts thereof wherein R is phenyl, halogen-substituted phenyl, lower alkyl-substituted phenyl, pyridyl or 5-methyl-1,3,4-oxadiazol-2-yl.These quinuclidine compounds are useful as anti-diarrheal agents.
Abstract: The present invention provides Diaryl-(1-azabicyclo [2.2.2]octan-2-yl)alkanols of the formula ##STR1## and the pharmaceutically acceptable acid addition salts thereof wherein R is a cycloalkanol having 4-8 carbon atoms, an alkanol having 1-2 carbon atoms, or a radical of the formula ##STR2## wherein R.sub.1 and R.sub.2 are each H or a C.sub.1 -C.sub.5 alkyl, and R.sub.3 is H or an acyl of the formula ##STR3## wherein R.sub.4 is H or a C.sub.1 -C.sub.4 alkyl. These alkanols are useful as antidiarrheal agents.
Abstract: This invention encompasses novel 1-(3,3-diaryl-3-oxadiazolalkyl)-4-phenyl-4-piperidinomethanols and related compounds. These compounds are useful anti-diarrheal agents which possess little or no analgesic activity.
Abstract: The reaction of 1-(halo/cyano/sulfonyloxy)alkanoyl-2-(dibenzoxazepine-10-carbonyl)hydrazin es with an amine affords the corresponding 1-(substituted amino)alkanoyl-2-(dibenzoxazepine-10-carbonyl)hydrazines which compounds are useful anti-inflammatory or anti-diarrheal agents.
Abstract: The invention relates to copolymers of 5-hydroxycytidylic acid and at least one other polynucleotide selected from cytidylic acid and monomers derived therefrom by bromination. The polymers of the invention are prepared by the bromination of polycytidylic acid and subsequent hydrolysis of the product. The copolymers of the invention demonstrate antiviral properties in vivo.
Abstract: Compounds of the formula ##STR1## wherein R is phenyl cyclohexyl or lower alkyl containing 1-6 carbon atoms; R" is hydrogen or methyl; R'" is alkenyl or alkynyl having 3-5 carbon atoms; R' is hydrogen, tetrahydrofuran-2-yl tetrahydropyran-2-yl or trialkylsilyl wherein the alkyl contains 1-4 carbon atoms. Compounds of the present invention are useful in synthesizing prostaglandin like molecules which are active anti-secretory agents.
Abstract: An improved process for cleaving peptides bound to a polymer by way of a benzylester linkage during solid phase peptide synthesis, the improvement comprising hydrogenolysis of said linkage by catalytic hydrogenation using a palladium (II) salt with a weak acid anion as the catalyst.
Abstract: The present invention relates to 3-alkoxy-D-homo-C-nor-13.alpha.,14.alpha.-gona-1,3,5(10),6,8-pentaen-17-on e and certain derivatives thereof. The compounds of this invention display valuable pharmacological activities, such as antispasmodic utility.
Abstract: The compounds of the present invention are useful intermediates for the manufacture of 3,5-dihydroxy-2-(.omega.-halo-3-hydroxy-1-alkenyl)cyclopentane-1-heptanoic acids and derivatives thereof. The latter compounds display valuable pharmacological properties, e.g. anti-fertility, bronchodilating, anti-secretory, smooth muscle stimulator and blood platelet aggregation-inhibiting.
Abstract: Analogs of enkephalin having agonist activity at opiate receptors are disclosed herein. These analogs are useful as analgesics, non-addicting narcotic antagonists and anti-diarrheal agents.
Type:
Grant
Filed:
May 7, 1976
Date of Patent:
June 7, 1977
Assignee:
G. D. Searle & Co.
Inventors:
David A. Jones, Jr., James M. Schlatter, Richard A. Mikulec, Judith A. Reuter, Robert H. Mazur
Abstract: The above-captioned compounds, prepared by coupling of a protected L-aspartic acid derivative with the appropriate amine followed by cleavage of the protecting groups, are potent sweetening agents and exhibit also pharmacological, e.g. anti-inflammatory, properties.
Type:
Grant
Filed:
February 14, 1974
Date of Patent:
March 8, 1977
Assignee:
G. D. Searle & Co.
Inventors:
Arthur H. Goldkamp, Robert H. Mazur, James M. Schlatter
Abstract: Deuterated analogs of prostaglandins have been prepared and found to display increased activity as antifertility, bronchodilator and/or bronchoconstrictor agents compared to the natural prostaglandins. The analogs are conveniently prepared by reduction of the 15-keto group and/or the 9-keto group with a deuterated reducing agent.
Abstract: Peptides containing the residues of methionine and aspartic acid are prepared by standard coupling techniques and display valuable pharmacological, e.g. gastrin-inhibitory, properties.